Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2019
June 29, 2019 at 02:02 am IST
Share
Remedent, Inc. announced earnings results for the full year ended March 31, 2019. For the full year, the company announced sales was USD 1.603 million compared to USD 2.699 million a year ago. Operating loss was USD 717,347 compared to USD 300,764 a year ago. Net income was USD 2.128 million compared to net loss of USD 54,591 a year ago. Basic earnings per share from continuing operations was USD 0.011 compared to USD 0 a year ago. Diluted earnings per share from continuing operations was USD 0.02 compared to USD 0 a year ago.
Remedent, Inc. specializes in the research, development and manufacturing of oral care and cosmetic dentistry products. The Company designs, develops, manufactures and distributes its cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, Middle East and the United States. The Company's operating segment consists of dental products and oral hygiene products sold by Remedent Inc., Remedent N.V., and Biotech Dental Benelux N.V. The Company offers over-the-counter (OTC) tooth whitening products. It has three primary products: River 8, a prefabricated veneer; its custom-made GlamSmile Veneers and the SmileMe mirror. The Company has developed a range of prefabricated, ready-to-use veneers that the Company has branded as River8. The Company's product in the professional oral care and cosmetic dentistry is the GlamSmile veneer. The SmileMe Mirror enables the dentist to offer patients a complete Smile Consultation.
REMEDENT, INC. 